Christopher A. Yasenchak

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Christopher A. Yasenchak

Feb 13, 2025, 06:52 | Drugs

FDA Approved Brentuximab Vedotin Combo for Relapsed/Refractory LBCL

On February 11, 2025, the FDA approved the use of brentuximab vedotin (Adcetris, Seagen Inc.,…

All: 1 Posts: 1 - 100

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

'

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

'

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

'

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023